Office of Research & Development |
|
Project Number: | I01BX005651-01A2 |
Title: | Establishing the Therapeutic Efficacy of Alpha-1-Antitrypsin and Enoxaparin Against COVID-19 |
Principal Investigator: | Edward D. Chan |
Location: | Denver, CO |
Congressional District Code: | 1 |
Research Service: | Biomedical Laboratory R&D |
Project Period: | July 2023 - June 2027 |
FY 2024 Funding Amount: | $211,176 |
Abstract: |
View abstract and other project information on NIH RePORTER Go To NIH RePORTER |